Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Uniunea Europeană - română - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - virusul gripei de suprafață (hemaglutinină și neuraminidază) de tulpina a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccinuri - imunizarea activă împotriva subtipului h5n1 al virusului gripal a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Uniunea Europeană - română - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccinuri - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Zoonotic Influenza Vaccine Seqirus Uniunea Europeană - română - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vaccinuri - active immunisation against h5 subtype of influenza a virus.

Pandemic Influenza Vaccine H5N1 Baxter AG Uniunea Europeană - română - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 baxter ag

resilience biomanufacturing ireland limited - (virion întreg, inactivat) care conține antigenul: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccinuri - profilaxia gripei într-o situație pandemică declarată oficial. vaccinul antigripal pandemic trebuie utilizat în conformitate cu orientările oficiale.

Focetria Uniunea Europeană - română - EMA (European Medicines Agency)

focetria

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 - influenza, human; immunization; disease outbreaks - vaccinuri pentru gripă - profilaxia gripei cauzate de virusul a (h1n1v) 2009. focetria ar trebui să fie utilizate în conformitate cu recomandările oficiale.

ENCEPUR ADULTI 1,5 µg/0,5 ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

encepur adulti 1,5 µg/0,5 ml

gsk vaccines gmbh - germania - vaccin impotriva encefalitei de capuse - susp. inj. in seringa preumpluta - 1,5µg/0,5ml - vaccinuri virale vaccinuri contra encefalitei

ENCEPUR COPII 0,75 µg/0,25 ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

encepur copii 0,75 µg/0,25 ml

gsk vaccines gmbh - germania - vaccin impotriva encefalitei de capuse - susp. inj. in seringa preumpluta - 0,75µg/0,25ml - vaccinuri virale vaccinuri contra encefalitei

Spikevax (previously COVID-19 Vaccine Moderna) Uniunea Europeană - română - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

RABIPUR, vaccin rabic inactivat pentru uz uman România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rabipur, vaccin rabic inactivat pentru uz uman

novartis vaccines and diagnostics gmbh - vaccin rabic inactivat - pulb. liof. + solv. pt. sol. inj. i.d. - 2,5ui/ml - vaccinuri virale vaccinuri rabice

RABIPUR, vaccin rabic inactivat pentru uz uman România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rabipur, vaccin rabic inactivat pentru uz uman

gsk vaccines gmbh - vaccin rabic inactivat - pulb. liof. + solv. pt. sol. inj. i.d. - 2,5ui/ml - vaccinuri virale vaccinuri rabice